Prime Medicine has surged over 130% in three months, driven by pipeline progress and visibility from recent scientific presentations. Learn more about PRME stock here.

A city research centre plans to use tomatoes to test the impact of gene-edited food in what is thought to be the first human ...

Gene therapies for rare diseases are frequently developed then discarded by drug companies because they can’t afford to ...

Turning genes on and off is like flipping a light switch, controlling whether genes in a cell are active. When a gene is ...

Researchers from the Department of Biomedical Engineering at UNIST and the Center for Genomic Integrity at the Institute for Basic Science (IBS) have announced an advance in cancer gene therapy. Their ...

The event, titled “Investing in a Resilient Future: Innovation, Data & Capital for Energy, Food, Water, and Climate Solutions”, supported by Syntax Data, will be held on Tuesday, September 23rd at ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that longer-term data from the ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine ...

A Mexico-based research centre believes it may have hit the bull’s eye when it comes to using technology to enhance crop ...

A plan to genetically engineer a version of the dodo, a giant flightless bird that disappeared 400 years ago and became the ...

Researchers from MIT have incorporated several modifications to prime editing systems, making them up to 60 times more ...

PlantArcBio, an Israeli ag-biotech firm, has secured patents in the U.S. and South Korea for its DIPPER platform. This ...